To reconstitute the human immune system in mice, transgenic mice expressing human CD4 and human major histocompatibility complex (MHC) class II (DQw6) molecules in an endogenous CD4- and CD8-deficient background (mCD4/8-/-), after homologous recombination, have been generated. We report that expression of human CD4 molecule in mCD4/8-/- mice rescues thymocyte development and completely restores the T cell compartment in peripheral lymphoid organs. Upon vesicular stomatitis virus (VSV) challenge, the reconstituted mature T cell population effectively provide T help to B cells in immunoglobulin class switching from IgM to specific IgG-neutralizing antibodies. Human CD4+DQw6+ double transgenic mice are tolerant to DQw6 and the DQw6 molecule functions in antigen presentation, effectively generating a human MHC class II-restricted T cell response to streptococcal M6C2 peptide. These data show that both the hCD4 and DQw6 molecules are functional in mCD4/8-/- mice, fully and stably reconstituting this limb of the human immune system in mice. This animal model provides a powerful in vivo tool to dissect the human CD4-human class II MHC interaction, especially its role in human autoimmune diseases, superantigen-mediated diseases, and acquired immunodeficiency syndrome (AIDS).
Skip Nav Destination
Article navigation
1 November 1994
Article|
November 01 1994
Human CD4-major histocompatibility complex class II (DQw6) transgenic mice in an endogenous CD4/CD8-deficient background: reconstitution of phenotype and human-restricted function.
R S Yeung,
R S Yeung
Department of Immunology, Ontario Cancer Institute, University of Toronto, Canada.
Search for other works by this author on:
J M Penninger,
J M Penninger
Department of Immunology, Ontario Cancer Institute, University of Toronto, Canada.
Search for other works by this author on:
T M Kündig,
T M Kündig
Department of Immunology, Ontario Cancer Institute, University of Toronto, Canada.
Search for other works by this author on:
Y Law,
Y Law
Department of Immunology, Ontario Cancer Institute, University of Toronto, Canada.
Search for other works by this author on:
K Yamamoto,
K Yamamoto
Department of Immunology, Ontario Cancer Institute, University of Toronto, Canada.
Search for other works by this author on:
N Kamikawaji,
N Kamikawaji
Department of Immunology, Ontario Cancer Institute, University of Toronto, Canada.
Search for other works by this author on:
L Burkly,
L Burkly
Department of Immunology, Ontario Cancer Institute, University of Toronto, Canada.
Search for other works by this author on:
T Sasazuki,
T Sasazuki
Department of Immunology, Ontario Cancer Institute, University of Toronto, Canada.
Search for other works by this author on:
R Flavell,
R Flavell
Department of Immunology, Ontario Cancer Institute, University of Toronto, Canada.
Search for other works by this author on:
P S Ohashi,
P S Ohashi
Department of Immunology, Ontario Cancer Institute, University of Toronto, Canada.
Search for other works by this author on:
T W Mak
T W Mak
Department of Immunology, Ontario Cancer Institute, University of Toronto, Canada.
Search for other works by this author on:
R S Yeung
Department of Immunology, Ontario Cancer Institute, University of Toronto, Canada.
J M Penninger
Department of Immunology, Ontario Cancer Institute, University of Toronto, Canada.
T M Kündig
Department of Immunology, Ontario Cancer Institute, University of Toronto, Canada.
Y Law
Department of Immunology, Ontario Cancer Institute, University of Toronto, Canada.
K Yamamoto
Department of Immunology, Ontario Cancer Institute, University of Toronto, Canada.
N Kamikawaji
Department of Immunology, Ontario Cancer Institute, University of Toronto, Canada.
L Burkly
Department of Immunology, Ontario Cancer Institute, University of Toronto, Canada.
T Sasazuki
Department of Immunology, Ontario Cancer Institute, University of Toronto, Canada.
R Flavell
Department of Immunology, Ontario Cancer Institute, University of Toronto, Canada.
P S Ohashi
Department of Immunology, Ontario Cancer Institute, University of Toronto, Canada.
T W Mak
Department of Immunology, Ontario Cancer Institute, University of Toronto, Canada.
Online ISSN: 1540-9538
Print ISSN: 0022-1007
J Exp Med (1994) 180 (5): 1911–1920.
Citation
R S Yeung, J M Penninger, T M Kündig, Y Law, K Yamamoto, N Kamikawaji, L Burkly, T Sasazuki, R Flavell, P S Ohashi, T W Mak; Human CD4-major histocompatibility complex class II (DQw6) transgenic mice in an endogenous CD4/CD8-deficient background: reconstitution of phenotype and human-restricted function.. J Exp Med 1 November 1994; 180 (5): 1911–1920. doi: https://doi.org/10.1084/jem.180.5.1911
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement